These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34722189)

  • 41. Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes.
    Di Martino M; Vitale A; Ferraro D; Maniscalco M; Pisaniello D; Arenga G; Falaschi F; Terrone A; Iacomino A; Galeota Lanza A; Esposito C; Cillo U; Vennarecci G
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Liver transplantation in patients with hepatocellular carcinoma].
    Song GW; Hwang S; Lee SG
    Korean J Gastroenterol; 2010 Jun; 55(6):350-60. PubMed ID: 20571302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver transplantation for HCC: its role: Eastern and Western perspectives.
    Hwang S; Lee SG; Belghiti J
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):443-8. PubMed ID: 19885638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review article: liver transplantation for hepatocellular carcinoma - a critical appraisal of the current worldwide listing criteria.
    Menon KV; Hakeem AR; Heaton ND
    Aliment Pharmacol Ther; 2014 Oct; 40(8):893-902. PubMed ID: 25155143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: where do we stand?
    Fujiki M; Aucejo F; Choi M; Kim R
    World J Gastroenterol; 2014 May; 20(18):5308-19. PubMed ID: 24833861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current opinion on the role of resection and liver transplantation for hepatocellular cancer.
    Puneet P; Perera MT; Mirza DF
    Indian J Gastroenterol; 2012 Jun; 31(3):89-99. PubMed ID: 22711364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria.
    Elshamy M; Aucejo F; Menon KV; Eghtesad B
    World J Hepatol; 2016 Jul; 8(21):874-80. PubMed ID: 27478537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review.
    Levi Sandri GB; Ettorre GM; Giannelli V; Colasanti M; Sciuto R; Pizzi G; Cianni R; D'Offizi G; Antonini M; Vennarecci G; Lucatelli P
    Transl Gastroenterol Hepatol; 2017; 2():98. PubMed ID: 29264436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital.
    Togashi J; Akamastu N; Kokudo N
    Hepatobiliary Surg Nutr; 2016 Oct; 5(5):399-407. PubMed ID: 27826554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis.
    Bhoori S; Sposito C; Germini A; Coppa J; Mazzaferro V
    Transpl Int; 2010 Jul; 23(7):712-22. PubMed ID: 20492616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
    Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation.
    Kutlu R; Karatoprak S
    J Gastrointest Cancer; 2020 Dec; 51(4):1157-1164. PubMed ID: 32880041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results.
    Di Sandro S; Giacomoni A; Slim A; Lauterio A; Mangoni I; Mihaylov P; Pirotta V; Aseni P; De Carlis L
    Hepatogastroenterology; 2012; 59(114):505-10. PubMed ID: 22353516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria.
    Bhangui P; Saigal S; Gautam D; Piplani T; Choudhary N; Chaudhary R; Yadav S; Thiagarajan S; Rastogi A; Saraf N; Nundy S; Soin AS
    Liver Transpl; 2021 Feb; 27(2):209-221. PubMed ID: 33253492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver transplantation for hepatocellular carcinoma.
    Chan SC
    Liver Cancer; 2013 Aug; 2(3-4):338-44. PubMed ID: 24400221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry.
    Kim JM; Kim DG; Kim J; Lee K; Lee KW; Ryu JH; Kim BW; Choi DL; You YK; Kim DS; Nah YW; Kang KJ; Cho JY; Hong G; Yu HC; Moon JI; Choi D; Hwang S; Kim MS
    Clin Mol Hepatol; 2021 Jul; 27(3):451-462. PubMed ID: 33525077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selecting the Appropriate Downstaging and Bridging Therapies for Hepatocellular Carcinoma: What Is the Role of Transarterial Radioembolization? A Pooled Analysis.
    Lopez-Lopez V; Miura K; Kuemmerli C; Capel A; Eshmuminov D; Ferreras D; Baroja-Mazo A; Cascales-Campos P; Jiménez-Mascuñán MI; Pons JA; Castellon MI; Sánchez-Bueno F; Robles-Campos R; Ramírez P
    Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Living donor liver transplantation for hepatocellular carcinoma in Indian patients- Is the scenario different?
    Pamecha V; Sinha PK; Rajendran V; Patil NS; Mohapatra N; Rastogi A; Patidar Y; Choudhury A
    Indian J Gastroenterol; 2021 Jun; 40(3):295-302. PubMed ID: 34019241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.